Published in

Elsevier, The Lancet Respiratory Medicine, 2023

DOI: 10.1016/s2213-2600(23)00376-4

Links

Tools

Export citation

Search in Google Scholar

Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial

Journal article published in 2023 by Frances C. Hall, Joseph Cheriyan, Andrew P. Cope, James Galloway, Ian Wilkinson, Simon Bond, Sam Norton, Edward Banham-Hall, Hannah Bayes, Michalis Kostapanos, Marianna Nodale, William G. Petchey, Thomas Sheeran, Jonathan Underwood, David R. Jayne and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO